Cholinesterase Inhibitors vs. Disease-Modifying Therapies: Market Share & Revenue Breakdown
Market Overview The Alzheimer's therapeutics market encompasses pharmaceutical formulations, biological agents, and novel pipeline compounds designed to slow cognitive decline, manage behavioral symptoms, and target underlying disease pathology. Valued robustly on a multi-billion-dollar scale, the market is projected to experience accelerated growth through the next decade, fueled by mounting...
0 Comments 0 Shares